Genmab A (GMAB) Cash & Current Investments (2018 - 2026)

Genmab A's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• Quarterly Cash & Current Investments fell 10.48% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 10.48% YoY) and the FY2025 annual result came in at $1.7 billion, up 23.29% from the prior year.
• Cash & Current Investments was $1.5 billion for Q1 2026 at Genmab A, down from $1.7 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $2.4 billion in Q4 2023 and bottomed at $2.0 million in Q2 2024.
• A 4-year average of $1.2 billion and a median of $1.5 billion in 2025 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments slumped 42.14% — and 2025, when it soared 70800.0%.
• Genmab A's Cash & Current Investments stood at $2.4 billion in 2023, then tumbled by 42.14% to $1.4 billion in 2024, then advanced by 23.29% to $1.7 billion in 2025, then dropped by 11.31% to $1.5 billion in 2026.
• Business Quant data shows GMAB's Cash & Current Investments at $1.5 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.9 billion in Q3 2025.